Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Venus Concept
Market Cap: US$2.3m
A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.
VERO
US$2.20
7D
-9.5%
1Y
-67.8%
Modern Mobility Aids
Market Cap: US$2.3m
Operates in the telehealth and telemedicine industry.
MDRM
US$0.0036
7D
-56.1%
1Y
-44.6%
One World Products
Market Cap: US$2.3m
One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.
OWPC
US$0.022
7D
5.2%
1Y
-62.2%
PHSC
Market Cap: UK£1.7m
Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.
PHSC
UK£0.17
7D
0%
1Y
-28.3%
Me Today
Market Cap: NZ$3.8m
Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.
MEE
NZ$0.07
7D
9.4%
1Y
-42.6%
NewGenIvf Group
Market Cap: US$2.2m
An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.
NIVF
US$2.95
7D
-12.7%
1Y
-98.7%
Cambium Bio
Market Cap: AU$3.5m
A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.
CMB
AU$0.19
7D
0%
1Y
-72.9%
Neural Therapeutics
Market Cap: CA$3.1m
A drug discovery company, focuses on plant-based active substances.
NURL
CA$0.035
7D
0%
1Y
n/a
Vectus Biosystems
Market Cap: AU$3.5m
Engages in the medical research and development activities in Australia.
VBS
AU$0.065
7D
0%
1Y
-67.5%
Helius Medical Technologies
Market Cap: US$2.2m
A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.
HSDT
US$4.27
7D
1.7%
1Y
-80.8%
AXIM Biotechnologies
Market Cap: US$2.2m
Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.
AXIM
US$0.0072
7D
-7.7%
1Y
-28.5%
Lifeline Biotechnologies
Market Cap: US$2.2m
Operates as a medical technology company in the United States.
LLBO
US$0.0004
7D
-20.0%
1Y
0%
TALi Digital
Market Cap: AU$3.3m
A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.
TD1
AU$0.001
7D
0%
1Y
-50.0%
Strainsforpains
Market Cap: US$2.1m
Operates as a medical marijuana data recommendation system.
EBYH
US$0.16
7D
0%
1Y
26.4%
CannaPharmaRX
Market Cap: US$2.1m
Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.
CPMD
US$0.0031
7D
-6.1%
1Y
-69.0%
Aptevo Therapeutics
Market Cap: US$2.1m
A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
APVO
US$0.32
7D
-5.9%
1Y
-98.9%
Revitalist Lifestyle and Wellness
Market Cap: CA$2.8m
Operates medical clinics.
CALM
CA$0.02
7D
0%
1Y
-80.0%
Entero Therapeutics
Market Cap: US$2.0m
A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
ENTO
US$0.42
7D
1.3%
1Y
-85.8%
Diagnamed Holdings
Market Cap: CA$2.8m
Engages in the development and commercialization of AI healthcare solutions.
DMED
CA$0.04
7D
100.0%
1Y
0%
Traack Technologies
Market Cap: US$2.0m
Provides business and finance advisory services for small and medium sized companies.
TRAA
US$0.18
7D
0%
1Y
88.1%
Agentix
Market Cap: US$2.0m
A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.
AGTX
US$0.05
7D
0%
1Y
41.0%
TNF Pharmaceuticals
Market Cap: US$2.0m
A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.
TNFA
US$0.19
7D
-0.6%
1Y
-92.0%
Craftport Cannabis
Market Cap: CA$2.7m
Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.
CFT
CA$0.045
7D
0%
1Y
50.0%
Radient Technologies
Market Cap: CA$2.7m
Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.
RTI.H
CA$0.005
7D
0%
1Y
n/a
JRSIS Health Care
Market Cap: US$1.9m
Develops and produces medical technology and equipment in the People’s Republic of China.
JRSS
US$0.023
7D
0%
1Y
n/a
DXS International
Market Cap: UK£1.4m
A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.
DXSP
UK£0.022
7D
0%
1Y
66.7%
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-86.8%
Universe Pharmaceuticals
Market Cap: US$1.9m
Through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.
UPC
US$5.49
7D
12.5%
1Y
-99.6%
Aditxt
Market Cap: US$1.9m
A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.
ADTX
US$1.66
7D
-4.0%
1Y
-100.0%
ZyVersa Therapeutics
Market Cap: US$1.9m
Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.
ZVSA
US$0.52
7D
-0.8%
1Y
-88.3%
Medical Marijuana
Market Cap: US$1.9m
An investment holding company, operates in the cannabinoid-based nutraceutical industry.
MJNA
US$0.00025
7D
-16.7%
1Y
-88.1%
Careteq
Market Cap: AU$2.8m
A medication management services company for health, aged, and home care sectors worldwide.
CTQ
AU$0.012
7D
-7.7%
1Y
-14.3%
Galera Therapeutics
Market Cap: US$1.8m
A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.
GRTX
US$0.024
7D
6.2%
1Y
-87.8%
Hellenic Dynamics
Market Cap: UK£1.4m
Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.
HELD
UK£0.0095
7D
0%
1Y
-75.3%
ENDRA Life Sciences
Market Cap: US$1.8m
Develops technologies to improve the capabilities of clinical diagnostic ultrasound.
NDRA
US$3.23
7D
-0.9%
1Y
-99.4%
OMID Holdings
Market Cap: US$1.8m
A health and wellness company, engages in the manufacture and sale of CBD-based products.
OMID
US$0.018
7D
-15.9%
1Y
-38.3%